these in vitro results suggest that tobramycin , sisomicin , or amikacin in combination with carbenicillin would be the safest initial regimen in the therapy of gentamicin-resistant pseudomonas infections pending susceptibility studies .
C0002499
amikacin
C0033817
pseudomonas